Gill TM, Feinstein AR. A critical appraisal of the quality of life measurements. JAMA 1994; 272: 619-626.
Fallowfield L. Quality of quality of life data. Lancet 1996; 348: 421.
Sanders C, Egger M, Donovan J, Tallon D, Frankel S. Reporting on quality of life in randomized controlled trials: bibliographic study. Br Med J 1998; 317: 1191-1194.
Winer EP. Quality of life research in patients with breast cancer. Cancer 1994; 74: 410-415.
Bowling A. Measuring disease: a review of disease-specific quality of life measurement scales. Buckingham: Open University Press, 1995.
Montazeri A, Harirchi I, Vahdani M, et al. The Euro-pean Organization for research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): translation and validation study of the Iranian version. Support Care Cancer 1999; 7: 400-406.
Sprangers MAG, Groenvold M, Arraras JI, et al. The European Organization for Research and Treatment of Cancer Breast Cancer-Specific Quality of Life Question-naire module: first results from a three-country field study. J Clin Oncol 1996; 14: 2756-2768.
Cull A, Sprangers M, Aaronson N. EORTC quality of life study group translation procedure (Internal report). Brussels: EORTC Quality of Life Study Group, 1994.
Zubord CG, Scheiderman MA, Frei E. Appraisal of methods for the study of chemotherapy in man: compara-tive therapeutic trial of nitrogen mustard and triethylene thiopphosphoramide. J Chro Dis 1960; 11: 7-33.
Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297-334.
Nunnally JC. Psychometric theory. New York: McGraw-Hill, 1994.
Kerlinger FN. Foundations of behavioral research. New York: Holt, Rinehart & Winston, 1973.
Fayers P, Aaronson N, Bjordal, Sullivan M. EORTC-C30 scoring manual. Brussels: EORTC Study Group on Quality of Life, 1995.
Hunt SM. Cross-cultural issues in the use of sociomedical indicators. Health Policy 1986; 6: 149-158.
Hunt SM, Alonso J, Bucquet D, Niero M, Wiklund I, McKenna S. Cross cultural adaptation of health measures. Health Policy 1991; 19: 33-44.
Brady MJ, Cella DF, Mo F, et al. Reliability and validity of the Functional Assessment of Cancer Therapy Breast quality oflife instrument. J Clin Oncol 1997; 15: 974-986.
Cella D, Hernandez L, Bonomi AE, et al. Spanish language translation and initial validation of the functional assess-ment of cancer therapy quality of life. Med Care 1998; 36: 1407-1418.
Hann DM, Jacobsen PB, Azzarello LM, et al. Measure-ment of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory. Qual Life Res 1998; 7: 301-310.
Bjordal K, Hammerlid E, Ahlner-Elmqvist M, et al. Quality of life in head and neck cancer patients: validation of the European Organization for Research and Cancer Treatment Quality of Life Questionnaire-H&N35. J Clin Oncol 1999; 17: 1008-1019.
Kobayashi K, Takeda F, Teramukai S, et al. A cross-vali-dation of the European Organization for Research and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30) for Japanese with lung cancer. Eur J Cancer 1998; 34: 810-815.
Aaronson NK, Ahmedzai S, Bergman B, et al. The Euro-pean Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in interna-tional clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-376.
Sprangers MAG, Cull A, Bjordal K, Groenvold M, Aaronson NK. The European Organization for Research and Treatment of Cancer approach to quality of life assessment: guideline for developing questionnaire modules. Qual Life Res 1993; 2: 287-295.
Sprangers MAG, Cull A, Groenvold M, Bjordal K, Blazeby J, Aaronson NK. The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules: an update and overview. Qual Life Res 1998; 7: 291-300.